Immune Response News and Research

RSS
UK's COVID-19 booster program accelerated, and people urged to get top-up jabs

UK's COVID-19 booster program accelerated, and people urged to get top-up jabs

5 Dec 2021
SARS-CoV-2 ORF10 degrades mitochondrial antiviral signaling protein to suppress immune response

SARS-CoV-2 ORF10 degrades mitochondrial antiviral signaling protein to suppress immune response

5 Dec 2021
Preclinical data shows enhanced T-cell responses & neutralization of SARS-CoV-2 variants with ImmunityBio heterologous vaccination

Preclinical data shows enhanced T-cell responses & neutralization of SARS-CoV-2 variants with ImmunityBio heterologous vaccination

5 Dec 2021
New approach to COVID-19 immune profiling using blood-based machine learning

New approach to COVID-19 immune profiling using blood-based machine learning

5 Dec 2021
Exposure to Chikungunya may offer partial cross-protection against Mayaro virus

Exposure to Chikungunya may offer partial cross-protection against Mayaro virus

4 Dec 2021
'Combination' adjuvant may boost the protective power of vaccines

'Combination' adjuvant may boost the protective power of vaccines

4 Dec 2021
Effectiveness of COVID-19 vaccines in New York State

Effectiveness of COVID-19 vaccines in New York State

3 Dec 2021
Subcutaneously administered monoclonal antibodies associated with reduced hospitalization and death amongst COVID 19 outpatients

Subcutaneously administered monoclonal antibodies associated with reduced hospitalization and death amongst COVID 19 outpatients

3 Dec 2021
CRISPR-based DETECTR® assay for faster SARS-CoV-2 surveillance

CRISPR-based DETECTR® assay for faster SARS-CoV-2 surveillance

3 Dec 2021
Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

Novel peptide-antibody fusion molecule enhances SARS-CoV-2 variant neutralization

3 Dec 2021
Modulating the composition of bacterial populations in the colon could enhance anti-tumor immunity

Modulating the composition of bacterial populations in the colon could enhance anti-tumor immunity

3 Dec 2021
Hybrid immunity provides the highest and most durable immunity against SARS-CoV-2 infection

Hybrid immunity provides the highest and most durable immunity against SARS-CoV-2 infection

2 Dec 2021
In-depth analysis of SARS-CoV-2 specific T cells in unexposed individuals

In-depth analysis of SARS-CoV-2 specific T cells in unexposed individuals

2 Dec 2021
Cedars-Sinai researchers uncover the cause of UTI-induced delirium

Cedars-Sinai researchers uncover the cause of UTI-induced delirium

2 Dec 2021
Immune cells play a much larger role in the onset of allergies than previously thought

Immune cells play a much larger role in the onset of allergies than previously thought

2 Dec 2021
NEI researchers identify unique population of B cells that tamps down the immune system

NEI researchers identify unique population of B cells that tamps down the immune system

2 Dec 2021
Advancing our understanding of T cells to improve cancer therapies

Advancing our understanding of T cells to improve cancer therapies

2 Dec 2021
Impact of SARS-CoV-2 infection on testis function

Impact of SARS-CoV-2 infection on testis function

2 Dec 2021
Systematic survey of human SARS-CoV-2 monoclonal antibodies

Systematic survey of human SARS-CoV-2 monoclonal antibodies

2 Dec 2021
SARS-CoV-2 infection risks increase with time in fully vaccinated adults

SARS-CoV-2 infection risks increase with time in fully vaccinated adults

1 Dec 2021

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback